CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Paul A. Beavis, Amanda X. Y. Chen et al.|Nature Communications|2021Cited by 206
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Phillip K. Darcy|Cancer Research|2017Cited by 72